Chronic kidney disease in primary care: An opportunity for generalists

Journal of General Internal Medicine

Volumn 26, Issue 4, 2011, Pages 356-358

  Tuot, Delphine S ^a   Powe, Neil R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ANGIOTENSIN RECEPTOR ANTAGONIST; BICARBONATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MEDICAL RESEARCH; MORTALITY; PRIMARY MEDICAL CARE; RISK REDUCTION;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE;

EID: 79953730561     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1650-8     Document Type: Article

References (31)

1. J Coresh E Selvin LA Stevens, et al. 2007 Prevalence of chronic kidney disease in the United States JAMA. 298 17 2038 47 17986697 10.1001/jama.298.17. 2038 1:CAS:528:DC%2BD2sXht1yjsLnM (Pubitemid 350074801)
2. LE Boulware MU Troll BG Jaar DI Myers NR Powe 2006 Identification and referral of patients with progressive CKD: a national study Am J Kidney Dis. 48 2 192 204 16860184 10.1053/j.ajkd.2006.04.073 (Pubitemid 44069609)
3. I Guessous W McClellan S Vupputuri H Wasse 2009 Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study BMC Nephrol 10 1 25 19758452 10.1186/1471-2369-10-25
4. AS Go GM Chertow D Fan CE McCulloch CY Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med. 351 13 1296 305 15385656 10.1056/NEJMoa041031 1:CAS:528:DC%2BD2cXnvFSgtr8%3D (Pubitemid 39268908)
5. M Tonelli N Wiebe B Culleton, et al. 2006 Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol. 17 7 2034 47 16738019 10.1681/ASN.2005101085 (Pubitemid 44036188)
6. I Gorodetskaya S Zenios CE McCulloch, et al. 2005 Health-related quality of life and estimates of utility in chronic kidney disease Kidney Int. 68 6 2801 8 16316356 10.1111/j.1523-1755.2005.00752.x (Pubitemid 43251026)
7. Plantinga LC, Johansen K, Crews DC, et al. Association of CKD With Disability in the United States. Am J Kidney Dis. 2011;57(2):212-7.
8. M Kurella Tamura V Wadley K Yaffe, et al. 2008 Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Am J Kidney Dis 52 2 227 34 18585836 10.1053/j.ajkd.2008.05.004 (Pubitemid 351978145)
9. MT James H Quan M Tonelli, et al. 2009 CKD and risk of hospitalization and death with pneumonia Am J Kidney Dis. 54 1 24 32 19447535 10.1053/j.ajkd.2009.04.005
10. MJ Sarnak AS Levey AC Schoolwerth, et al. 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension. 42 5 1050 65 14604997 10.1161/01.HYP.0000102971.85504.7c 1:CAS:528:DC%2BD3sXosFCls70%3D (Pubitemid 37413751)
11. MJ Sarnak T Greene X Wang, et al. 2005 The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study Ann Intern Med. 142 5 342 51 15738453 (Pubitemid 40293407)
12. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med. 358 24 2560 72 18539916 10.1056/NEJMoa0802987 1:CAS:528:DC%2BD1cXnt1yht7s%3D (Pubitemid 351831357)
13. A Patel S MacMahon J Chalmers, et al. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet. 370 9590 829 40 17765963 10.1016/S0140-6736(07)61303-8 1:CAS:528:DC%2BD2sXhtVWjs7zO (Pubitemid 47362321)
14. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280 e1-7.
15. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 78(3):303-9.
16. Navaneethan SD, Pansini F, Perkovic V, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009(2):CD007784.
17. HR Martinez-Ramirez B Jalomo-Martinez L Cortes-Sanabria, et al. 2006 Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist Am J Kidney Dis. 47 1 78 87 16377388 10.1053/j.ajkd.2005.09.015 1:CAS:528:DC%2BD28Xpt1elsg%3D%3D (Pubitemid 41828269)
18. KS Kinchen J Sadler N Fink, et al. 2002 The timing of specialist evaluation in chronic kidney disease and mortality Ann Intern Med. 137 6 479 86 12230348 (Pubitemid 35024618)
19. Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. doi: 10.1007/s11606-010-1511-x
20. Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med. doi: 10.1007/s11606-010-1523-6
21. AM O'Hare AI Choi D Bertenthal, et al. 2007 Age affects outcomes in chronic kidney disease J Am Soc Nephrol. 18 10 2758 65 17855638 10.1681/ASN.2007040422 (Pubitemid 47531203)
22. CA Peralta LS Hicks GM Chertow, et al. 2005 Control of hypertension in adults with chronic kidney disease in the United States Hypertension. 45 6 1119 24 15851626 10.1161/01.HYP.0000164577.81087.70 1:CAS:528:DC%2BD2MXkt1OlsLk%3D (Pubitemid 40770315)
23. LC Plantinga ER Miller 3rd LA Stevens, et al. 2009 Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006 Hypertension. 54 1 47 56 19470881 10.1161/HYPERTENSIONAHA.109. 129841 1:CAS:528:DC%2BD1MXntVyrtro%3D
24. Tuot DS, Plantinga L, Hsu C-y, Powe NR. Is awareness of chronic kidney disease associated with greater achievement of evidence-based medical therapies? J Am Soc Nephrol. 2010;21:132A.
25. Plantinga L, Grubbs V, Hsu C-y, et al. High non-steroidal anti-inflammatory drug use among persons with chronic kidney disease in the U.S. J Am Soc Nephrol. 2010;21:665A.
26. N Volkova W McClellan M Klein, et al. 2008 Neighborhood poverty and racial differences in ESRD incidence J Am Soc Nephrol. 19 2 356 64 18057219 10.1681/ASN.2006080934 (Pubitemid 351240656)
27. Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE. Quality of patient-physician discussions about CKD in primary care: A cross-sectional study. Am J Kidney Dis. 2010 [Epub ahead of print]
28. Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 17(3):225-36.
29. Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011 [Epub ahead of print]
30. RC Greer NR Powe BG Jaar MU Troll LE Boulware 2011 Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions BMC Nephrol 12 1 1 21235763 10.1186/1471-2369- 12-1 [Epub ahead of print]
31. Saran R, Hedgeman E, Plantinga L, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 5(1):152-61.